SCHEMBL18650245

SCHEMBL18650245

Cc1ccc(-c2c3cc(F)c(=O)cc-3oc3cc(O)c(F)cc23)c(C)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 2/20 0.65
POLB P06746 7/20 0.46
MEN1 O00255 7/20 0.46
KMT2A Q03164 7/20 0.46
BLM P54132 6/20 0.46
MAPT P10636 6/20 0.46
USP2 O75604 6/20 0.46
KDM4E B2RXH2 6/20 0.46
GAA P10253 5/20 0.46
L3MBTL1 Q9Y468 5/20 0.46
RECQL P46063 5/20 0.46
TDP1 Q9NUW8 5/20 0.46
MAPK1 P28482 4/20 0.46
THRB P10828 4/20 0.46
HPGD P15428 5/20 0.43
ALDH1A1 P00352 4/20 0.43
HSP90AA1 P07900 2/20 0.43
CASP6 P55212 2/20 0.43
CASP7 P55210 2/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18653024 0.87 FTO (0.72) FTOPOLBMEN1KMT2ABLM
SCHEMBL17695445 0.87 FTO (0.76) FTOPOLBMEN1KMT2ABLM
SCHEMBL22128453 0.87 FTO (0.60) FTOPOLBMEN1KMT2ABLM
SCHEMBL19676682 0.87 FTO (0.63) FTOPOLBMEN1KMT2ABLM
SCHEMBL10291501 0.87 FTO (0.58) FTOPOLBMEN1KMT2ABLM
SCHEMBL22139497 0.87 FTO (0.60) FTOPOLBMEN1KMT2ABLM
SCHEMBL22139485 0.87 FTO (0.69) FTOPOLBMEN1KMT2ABLM
SCHEMBL21945700 0.87 FTO (0.60) FTOPOLBMEN1KMT2ABLM
SCHEMBL22139508 0.87 FTO (0.60) FTOPOLBMEN1KMT2ABLM
SCHEMBL10260320 0.87 FTO (0.76) FTOPOLBMEN1KMT2ABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170082642-A1 FLUORESCENT CELL MARKERS KODE BIOTECH LTD (NZ) 2017-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170082642-A1 FLUORESCENT CELL MARKERS PTDSS2, SPTLC2, CD69 FTO 2753/4885POLB 4116/4885MEN1 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.